Shares of Castle Biosciences dropped 8.45% to $59.45 at 14:27 EST on Tuesday, after four successive sessions in a row of losses. NASDAQ Composite is sliding 1% to $13,774.94, following last session’s downward trend, This seems, up to now, a somewhat rough trend trading session today.
Castle Biosciences’s last close was $64.94, 81.14% under its 52-week high of $107.69.
The company’s growth estimates for the present quarter and the next is a negative 900% and a negative 150%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth declined by 1.9%, now sitting on 62.65M for the twelve trailing months.
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $59.45 at 14:27 EST, way below its 52-week high of $107.69 and way higher than its 52-week low of $26.13.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way below its 50-day moving average of $71.54 and under its 200-day moving average of $63.56.
More news about Castle Biosciences.